宁波泰斯拓生物

www.testobio.com
  • 本公司产品仅供体外研究使用,不用于临床诊断
首页  /  产品中心  /  进口菌株

产品中心

试剂盒
菌株
质粒
试剂
联系我们  CONTACT US

0574-87917803

testobio@163.com

浙江省宁波市镇海区庄市街道兴庄路9号创e慧谷42号楼B幢401室
最新促销

货号: TS263591

名称: Candida metapsilosis


货号: TS263592

名称: Candida sake


货号: TS131909

名称: HFBCI28


货号: TS131910

名称: Septoria passiflorae Sydow, anamorph


货号: TS131911

名称: Graphium cuneiferum (Berkeley et Broome) Mason et Ellis


货号: TS131912

名称: Streptomyces scabiei (Thaxter) Lambert and Loria


货号: TSTOA0001

名称: Marisediminicola antarctica


货号: TS276951

名称: Real Time PCR EasyTM-Taqman


货号: TS276952

名称: Bacillus subtilis


货号: TS276954

名称: Bacillus subtilis

A431NS

货号 TS212729
中文名称 null
适应种属
检测范围
微信小陈 微信小章
在线留言
产品简介
购买须知
产品名称: A431NS
商品货号: TS212729
Organism: Homo sapiens, human
Tissue: skin/epidermis
Product Format: frozen
Morphology: epithelial
Culture Properties: adherent
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: epidermoid carcinoma
Age: 85 years
Gender: female
Applications:
While cell sensitivity to drugs tend to be changeable, the A431NS cell line has a stable sensitivity to LIC. The cell line can be used to test the antiproliferation activity of LIC.
Storage Conditions: liquid nitrogen vapor temperture
Derivation:
A431NS was derived from the A431 cell line (ATCC CRL-1555) in 1997 by repeated subculturing to select cells that detached from the substrate easily.
Clinical Data:
female
85 years
Comments:

The polyinosinic-polycytidylic acid/cationic liposome complex (LIC) inhibits cancer cell growth by the induction of apoptosis.

LIC has strong cytotoxic effects on the A431NS cell line but neither polyinosinic-polycytidylic acid alone nor cationic liposome alone have antiproliferation effects.

Complete Growth Medium: The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing: Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
  1. Remove and discard culture medium. xa0xa0
  2. Briefly rinse the cell layer with PBS to remove all traces of serum which contains trypsin inhibitor. xa0xa0
  3. Remove the PBS completely and add 2.0 to 3.0 ml ofxa0 0.25% (w/v) Trypsin-053mM EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually with 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach.xa0 Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Add 6.0 to 8.0 mL of complete growth medium containing 10% FBS and aspirate cells by gently pipetting.xa0 xa0
  5. To remove trypsin-EDTA solution, transfer cell suspension to centrifuge tube and spin at approximately 125 x g for 5 to 10 minutes. xa0 xa0
  6. Discard supernatant and resuspend cells in fresh culture medium.xa0 Add appropriate aliquots of cell suspension to new culture vessels.
  7. Place culture vessels in incubators at 37°C.xa0

Subcultivation Ratio:xa0 1:3 to 1:6.
Medium Renewal: Every 2 to 3 days.
Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994

Cryopreservation:
Freeze medium: Complete growth medium 95%; DMSO, 5%
Storage temperature: liquid nitrogen vapor temperture
Culture Conditions:
Temperature: 37°C
STR Profile:
Amelogenin: X
CSF1PO: 11,12
D13S317: 9,13
D16S539: 12,14
D5S818: 12,13
D7S820: 10
THO1: 9
TPOX: 11
vWA: 15,17
Name of Depositor: K Hirabayashi
Deposited As: human
References:

Hirabayashi K, et al. Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity. Cancer Res. 59: 4325-4333, 1999. PubMed: 10485480